ibopamine has been researched along with Heart Failure in 149 studies
*Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 57 (38.26) | 18.7374 |
| 1990's | 86 (57.72) | 18.2507 |
| 2000's | 6 (4.03) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erhardt, PW | 1 |
| Petrie, CJ; van Veldhuisen, DJ; Voors, AA | 1 |
| Goldberg, LI; Rajfer, SI | 3 |
| Brusoni, B; Cadel, A; Ladelli, L; Mangiavacchi, M; Pezzano, A; Sala, G | 1 |
| Forattini, C; Gabellini, A; Reffo, GC; Turrin, M | 1 |
| Col, J; Mievis, E; Reynaert, M | 1 |
| Bernardini, B; Dei Cas, L; Manca, C; Mansour, M; Vasini, G; Zonca, A | 1 |
| Mengeot, P; Mirgaux, M; Piette, F | 1 |
| Andrews, R; Cowley, AJ; Evans, A; Walsh, JT | 1 |
| Azevedo, JE; Campos Filho, O; Cantarelli, MJ; Carvalho, AC; de Almeida, DR; Martinez Filho, EE; Smith, AC | 1 |
| Girbes, AR; Lie, KI; Lieverse, AG; Meijer, S; Reitsma, WD; Smit, AJ; Van Veldhuisen, DJ; Zijlstra, JG | 2 |
| Boomsma, F; Brouwer, J; Dunselman, PH; Haaksma, J; Lie, KI; Man in 't Veld, AJ; van Veldhuisen, DJ | 1 |
| Arcensio, SR; Arteaga, E; Barretto, AC; Bellotti, G; da Luz, PL; Mady, C; Pileggi, F; Szambock, F | 1 |
| Cas, LD; Metra, M; Missale, C; Spano, PF | 1 |
| Oosterbosch, C | 1 |
| Francis, GS | 1 |
| Pouleur, H | 1 |
| Dei Cas, L; Metra, M | 1 |
| de Voogt, WG; Groeneveld, AB; Hoekstra, OS; Holman, ND; Schneider, AJ; van der Meer, J | 1 |
| Brouwer, J; Dohmen, HJ; Dunselman, PH; Lie, KI; Lok, DJ; Man in 't Veld, AJ; Pasteuning, WH; Poortermans, JC; van Veldhuisen, DJ; Withagen, AJ | 1 |
| Ahn, S; Benedict, CR; Donckier, J; Galanti, L; Ketelslegers, JM; Kinan, D; Konstam, MA; Melin, J; Pouleur, H; Rousseau, MF | 1 |
| Lie, KI; van Zwieten, PA | 1 |
| Remme, WJ | 1 |
| Scheen, AJ | 1 |
| Girbes, AR; Kalisvaart, CJ; Pasteuning, WH; Reitsma, WD; Smit, AJ; Tan, ET; Van Veldhuisen, DJ | 1 |
| López-Sendón, JL | 1 |
| Bucx, JJ; Dankbaar, H; Huizing, G; Said, SA; van Gilst, WH | 1 |
| Parker, JO | 1 |
| Buikema, H; de Smet, BJ; Lie, KI; Scholtens, E; van Gilst, WH; van Veldhuisen, DJ; Wesseling, H | 1 |
| de Graeff, PA; Girbes, AR; Lie, KI; van den Broek, SA; van Gilst, WH; van Veldhuisen, DJ | 1 |
| Burri, M; Kehtari, R; Metzger, J; Reuge, L | 1 |
| Cosín Aguilar, J; Cruz Fernández, JM; de Teresa Galván, E; Ferreira Montero, IJ; López-Sendón, J; Soler Soler, J; Tamargo Menéndez, J | 1 |
| Girbes, AR; Kruik, J; Lie, KI; Szabó, BM; van der Burgh, PH; van Veldhuisen, DJ | 1 |
| Dei Cas, L; Metra, M; Nodari, S; Raccagni, D | 1 |
| Campa, PP; Dawodu, AA; De Biase, L; Gentile, C; Lilla Della Monica, PL; Monti, F; Puddu, PE; Schiariti, M; Vaccaro, M | 1 |
| Coats, AJ; Niebauer, J | 1 |
| Ardia, A; Block, P; Cortina, A; Cowley, AJ; Cserhalmi, L; Follath, F; Hampton, JR; Jensen, G; Kayanakis, J; Kleber, FX; Lie, KI; Mancia, G; Skene, AM; van Veldhuisen, DJ | 1 |
| Van Veldhuisen, DJ | 1 |
| Andrews, R; Charlesworth, A; Cowley, AJ; Evans, A | 1 |
| Massel, D | 1 |
| Girbes, AR; Zijlstra, JG | 1 |
| Hampton, JR | 1 |
| Dohmen, HJ; Dunselman, PH; Poole-Wilson, PA | 1 |
| Struthers, AD; Yee, KM | 1 |
| Girbes, AR; Smit, AJ | 1 |
| Feenstra, J; Grobbee, DE; Ottervanger, JP; Porsius, AJ; Stricker, BH | 1 |
| Mitha, AS; Naidoo, DP; Rocke, A | 1 |
| Feenstra, J; Grobbee, DE; in't Veld, BA; Stricker, BH; van der Linden, PD | 1 |
| de Graeff, PA; Elferink, AJ; Lekkerkerker, JF | 1 |
| Vandenbroucke, JP | 1 |
| Smit, AJ | 1 |
| Cobelli, F; Febo, O | 1 |
| Boomsma, F; Charlesworth, A; de Kam, PJ; de Zeeuw, D; Girbes, AR; Hampton, JR; Hillege, HL; van Veldhuisen, DJ | 1 |
| Charlesworth, A; Cowley, AJ; Hampton, JR; Kleber, FX; Van Veldhuisen, DJ | 1 |
| Feenstra, H; Grobbee, RE; in't Veld, BA; Stricker, BH | 1 |
| Poole-Wilson, PA; van Veldhuisen, DJ | 1 |
| Cabell, B; Glogar, D; Kleber, FX; Sabin, GV; Thyroff-Friesinger, U | 1 |
| Hayashida, W; Kawai, C; Kumada, T | 1 |
| Dei Cas, L; Metra, M; Visioli, O | 1 |
| Lotti, G; Musso, NR; Pouleur, H; Raigoso, J; Rousseau, MF; van Eyll, C; Van Mechelen, H | 1 |
| Itoh, H; Koike, A; Nakamura, S; Sato, Y; Taniguchi, K; Tsujibayashi, T | 1 |
| Astorga, MA; Ceia, F; Coelho, EM; Fonseca, C; Gil, V; Gomes, RS; Gouveia, R; Luís, AS; Mota, E; Riva, E | 1 |
| Man in't Veld, AJ | 1 |
| López-Sendón, J | 2 |
| Pouleur, H; Raigoso, J; Rousseau, MF | 1 |
| Crijns, HJ; Girbes, AR; Lie, KI; Tobé, TJ; Van Veldhuisen, DJ; Wiesfeld, AC | 1 |
| Girbes, AR; Smit, AJ; van Veldhuisen, DJ | 1 |
| Borchard, U | 1 |
| Kleber, FX | 1 |
| Theisen, K; Wehling, M | 1 |
| Itoh, H; Taniguchi, K; Tsujibayashi, T | 1 |
| Kleber, FX; Thyroff-Friesinger, U | 3 |
| Costa, R; De Marino, V; Marino, A | 1 |
| Bordoni, G; Castelli, N; Giannazzo, G; Mannolini, G; Pala, AM; Piccini, L | 1 |
| Cesana, B; Ferrari, V; Licciardello, L; Sher, D; Sirtori, F | 1 |
| Barabino, A; Galbariggi, G; Lotti, G; Pizzorni, C | 1 |
| Cicchetti, V; Taylor, SH | 1 |
| van Zwieten, PA | 1 |
| Marchetti, GV | 1 |
| Storstein, L | 1 |
| Bruzzone, F; Canale, C; Caponnetto, S; Licciardello, L; Marchetti, GV; Masperone, MA; Pastorino, L; Terrachini, V | 1 |
| Crijns, HJ; de Graeff, PA; Girbes, AR; Lie, KI; Smit, AJ; van Veldhuisen, DJ | 1 |
| Casagrande, C; La Regina, A; Merlo, L | 1 |
| Alunni, GF; Bardelli, G; Boschetti, E; Capponi, EA; Cocchieri, M; Del Favero, A; Fortunati, F; Regi, L | 1 |
| Gerzer, R; Theisen, K; Wehling, M; Weil, J; Zimmermann, J | 1 |
| Cutler, RE; Goldberg, P; Green, JA; Hricik, D; Jarvis, RC; Kasmer, RJ; Munger, MA; Nara, AR | 1 |
| Man in 't Veld, AJ | 1 |
| Holubarsch, C; Just, H | 1 |
| Benzi, L; Cecchetti, P; Ciccarone, AM; Cicchetti, V; Di Cianni, G; Navalesi, R; Sabino, F | 1 |
| Cicchetti, V; DiCarlo, A; Giannarelli, R; Marchetti, P; Navalesi, R; Sabino, F | 1 |
| Theisen, K; Wehling, M; Zimmermann, J | 1 |
| Azzolini, A; Colantoni, A; Guffanti, E; Pizzorni, C; Ronzitti, M; Tantalo, L | 1 |
| Compostella, L; Cucchini, F; Di Mario, C; Ghirardi, P; Iavernaro, A; Libardoni, M | 1 |
| Bruzzone, F; Canale, C; Caponnetto, S; Licciardello, L; Marchetti, GV; Terrachini, V | 1 |
| Dei Cas, L; Metra, M; Nodari, S; Visioli, O | 1 |
| Taylor, SH | 1 |
| Casagrande, C; Ferrini, R; Merlo, L; Miragoli, G; Semeraro, C | 1 |
| Dei Cas, L; Memo, M; Metra, M; Missale, C; Sigala, S; Spano, PF | 1 |
| Alicandri, C; Boni, E; Fariello, R; Muiesan, G; Zaninelli, A | 1 |
| Cantoni, V; Cicchetti, V; Ghirardi, P; Marchetti, GV; Rolandi, E; Sabino, F | 1 |
| Bonaduce, A; Cacciapuoti, F; Canale, C; Caponnetto, S; Cappello, C; Condorelli, M; Mattioli, G; Montemurro, A; Terrachini, V; Varricchio, M | 1 |
| Aggio, S; Ansani, L; Baracca, E; Ghirardi, P; Longhini, C; Musacci, GF; Toselli, T | 1 |
| Carey, RA; Jacob, L | 1 |
| Hasenfuss, G; Just, H | 1 |
| Abbondati, G; Cavalli, A; Fuccella, LM; Riva, E; Schleman, M | 1 |
| Abbondati, G; Cavalli, A; Cedrini, MC; Fuccella, LM; Riva, E; Schleman, M | 1 |
| Barriales, V; Cortina, A; Martínez Trabanco, I; Richard, JM | 1 |
| Hamada, M; Iwata, J; Kakuta, Y; Kasai, A; Konishi, T; Morimoto, Y; Nagano, K; Nakano, T; Umino, M | 1 |
| Lodola, E; Ventresca, GP | 1 |
| Byers, SL; Chaitman, BR; Labovitz, AJ; Mrosek, D; Stoddard, MF | 1 |
| Bussmann, WD; Frik, R; Wienhöfer, K | 1 |
| Isaka, N; Kakuta, Y; Kanamaru, M; Kodera, T; Konishi, T; Morimoto, Y; Nakano, T; Tekezawa, H | 1 |
| Dei Cas, L; Manca, C; Metra, M; Nodari, S; Riva, S; Visioli, O | 1 |
| Carini, L; Castini, D; Mazzola, C; Moreo, A; Salvadeo, A; Segagni, S; Segalini, G; Villa, G; Vitolo, E | 1 |
| Bianco, L; Cantoni, V; Cicchetti, V; Ghirardi, P; Marchetti, GV; Sabino, F | 1 |
| Azzollini, F; De Caro, L; Lodola, E; Longo, A; Pelosi, G; Rolandi, E; Ventresca, GP | 1 |
| Gandini, C; Melloni, GF; Melloni, R; Scarazatti, E | 1 |
| Lehto, H; Nieminen, MS; Partanen, J | 1 |
| Azzollini, F; Castelnovo, P; Cattò, G; Iacuitti, G; Longo, A; Pataccini, R; Pelosi, G; Picca, M; Pocchiari, F; Ventresca, GP | 1 |
| Conti, A; De Alfieri, W; Di Bari, M; Ferrucci, L; Lombardi, A; Marchionni, N; Moschi, G; Vannucci, A | 1 |
| Allegro, A; Bellotti, G; Boccanelli, A; Caponnetto, S; Cataldi, A; Gambelli, G; Portioli, I; Prati, PL; Salvemini, M; Zacharo, E | 1 |
| Kakuta, Y; Kanamaru, M; Kodera, T; Konishi, T; Morimoto, Y; Nakano, T; Takezawa, H | 1 |
| Ferrari, V; Sher, D | 1 |
| Marchetti, G; Merlo, L | 1 |
| Colombo, G; De Vita, C; Devizzi, S; Palvarini, M; Pataccini, R; Pocchiari, F; Triulzi, E | 1 |
| Castellaccio, M; Dore, L; Ibba, GV; Sannia, L | 1 |
| Camerini, F; Humar, F; Maras, P; Morgera, T | 1 |
| Bramucci, E; Gavazzi, A; Mussini, A | 1 |
| Brusoni, B; Cadel, A; Carati, L; Fanciulli, R; Osculati, G; Pirelli, P; Rovati, A; Valagussa, F | 1 |
| Aggio, S; Ansani, L; Baracca, E; Longhini, C; Musacci, GF; Toselli, T | 1 |
| Barilli, AC; Cavicchi, E; Dei Cas, L; Fracalossi, C; Lomanto, B; Longhini, C; Maggi, GC; Metra, M; Pinca, L; Santambrogio, S | 1 |
| Avanzini, Z; Bellogini, GC; Brusoni, B; Ciampani, N; Dei Cas, L; Gazzola, U; Maggi, GC; Mangiavacchi, M; Metra, M; Pinca, L | 1 |
| Ferrari, V; Marchetti, G; Sher, D | 1 |
| Castellaccio, M; Dore, L; Ibba, GV; Sannia, L; Scorcu, G | 1 |
| Douglas, FL; Goldberg, LI; Karrison, T; Rajfer, SI; Rossen, JD | 1 |
| Barreca, T; Cantoni, V; Cicchetti, V; Franceschini, R; Gianrossi, R; Marchetti, G; Rolandi, E | 1 |
| Bianco, L; Brusoni, B; Col, J; Dei Cas, L; Ghirardi, P; Mangiavacchi, M; Metra, M | 1 |
| Cicogna, R; Dei Cas, L; Fappani, A; Manca, C; Metra, M; Riva, S; Visioli, O | 1 |
| Dei Cas, L; Faggiano, P; Fappani, A; Ferrari, R; Giunti, G; La Canna, G; Riva, S; Zanini, R | 1 |
30 review(s) available for ibopamine and Heart Failure
| Article | Year |
|---|---|
In search of the digitalis replacement.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1987 |
Receptor systems involved in norepinephrine release in heart failure: focus on dopaminergic systems.
Topics: Deoxyepinephrine; Dopamine Agonists; Heart Failure; Humans; Norepinephrine; Receptors, Dopamine | 1995 |
Neurohormonal and hemodynamic effects of ibopamine.
Topics: Clinical Trials as Topic; Deoxyepinephrine; Dopamine Agonists; Heart Failure; Hemodynamics; Humans; Kidney; Levodopa; Norepinephrine; Ventricular Dysfunction, Left | 1995 |
Clinical efficacy of ibopamine in patients with chronic heart failure.
Topics: Clinical Trials as Topic; Deoxyepinephrine; Dopamine Agonists; Heart Failure; Hemodynamics; Humans; Kidney; Norepinephrine; Randomized Controlled Trials as Topic | 1995 |
[Neurohormonal compensation processes in chronic heart failure: the effect of drugs].
Topics: Adrenergic beta-Agonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiac Glycosides; Cardiotonic Agents; Deoxyepinephrine; Diuretics; Dobutamine; Heart Failure; Humans; Receptors, Cell Surface; Renin-Angiotensin System; Sympathetic Nervous System | 1994 |
[Chronic cardiac insufficiency: current treatment and future outlook].
Topics: Adrenergic Antagonists; Aldosterone; Angiotensin II; Cardiotonic Agents; Cardiovascular Agents; Clinical Protocols; Deoxyepinephrine; Digitalis Glycosides; Diuretics; Heart Failure; Humans; Vasoconstrictor Agents | 1996 |
[Neurohormonal factors in heart failure (and III)].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Diuretics; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Vasodilator Agents | 1996 |
Can drug effects on mortality in heart failure be predicted by any surrogate measure?
Topics: Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Biomarkers; Calcium Channel Blockers; Deoxyepinephrine; Dopamine Agonists; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate | 1997 |
Dopamine in heart failure and critical care.
Topics: Cardiotonic Agents; Controlled Clinical Trials as Topic; Critical Care; Deoxyepinephrine; Dopamine; Dopamine Agonists; Fenoldopam; Heart Failure; Hemodynamics; Humans; Treatment Outcome | 2000 |
[Exercise test in the evaluation of the efficacy of drug therapy].
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Digitalis; Evaluation Studies as Topic; Exercise Test; Follow-Up Studies; Heart Failure; Humans; Oxygen Consumption; Plants, Medicinal; Plants, Toxic; Time Factors; Vasodilator Agents; Xamoterol | 2000 |
The underreporting of results and possible mechanisms of 'negative' drug trials in patients with chronic heart failure.
Topics: Bosentan; Cardiovascular Agents; Deoxyepinephrine; Heart Failure; Humans; Imidazoles; Mibefradil; Pyrazines; Quinolines; Sulfonamides; Xamoterol | 2001 |
[New oral drugs for the treatment of congestive heart failure].
Topics: Administration, Oral; Cardiotonic Agents; Deoxyepinephrine; Ethanolamines; Heart Failure; Humans; Phosphodiesterase Inhibitors; Piperidines; Propanolamines; Pyrazines; Quinolines; Quinolones; Vasodilator Agents; Xamoterol | 1992 |
Ibopamine in the treatment of heart failure.
Topics: Cardiotonic Agents; Deoxyepinephrine; Dopamine Agents; Heart Failure; Humans; Vasodilator Agents | 1991 |
Ibopamine in chronic congestive heart failure: hemodynamic and neurohumoral effects.
Topics: Animals; Cardiotonic Agents; Deoxyepinephrine; Dopamine Agents; Heart; Heart Failure; Hemodynamics; Humans; Neurotransmitter Agents; Vasodilator Agents | 1991 |
[Ibopamine--pharmacologic principles].
Topics: Cardiotonic Agents; Deoxyepinephrine; Dopamine Agents; Heart; Heart Failure; Hemodynamics; Humans; Receptors, Adrenergic; Receptors, Dopamine | 1991 |
[Ibopamine--clinical results].
Topics: Cardiotonic Agents; Deoxyepinephrine; Dopamine Agents; Heart; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Prognosis | 1991 |
[Ibopamine--acute hemodynamic, renal and neurohumoral effects].
Topics: Cardiotonic Agents; Deoxyepinephrine; Dopamine Agents; Heart; Heart Failure; Hemodynamics; Hormones; Humans; Kidney Function Tests | 1991 |
[Physiological bases and therapeutic uses of inodilator drugs].
Topics: Amrinone; Cardiotonic Agents; Deoxyepinephrine; Dobutamine; Dopamine; Heart Failure; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Sympathomimetics; Vasodilator Agents | 1991 |
Efficacy of ibopamine in the treatment of heart failure.
Topics: Cardiotonic Agents; Deoxyepinephrine; Dopamine Agents; Heart Failure; Humans; Vasodilator Agents | 1990 |
Pharmacological profile of ibopamine. A summary of experiments on anaesthesized dogs.
Topics: Animals; Cardiotonic Agents; Deoxyepinephrine; Dogs; Dopamine Agents; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Receptors, Adrenergic; Receptors, Dopamine; Vasodilator Agents | 1990 |
Effect of ibopamine, a dopamine congener, on arrhythmias in heart failure.
Topics: Animals; Cardiotonic Agents; Deoxyepinephrine; Dopamine Agents; Electrocardiography, Ambulatory; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Tachycardia; Vasodilator Agents | 1990 |
Hemodynamic and neurohumoral effects of ibopamine in patients with chronic congestive heart failure.
Topics: Cardiotonic Agents; Deoxyepinephrine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Long-Term Care; Neurotransmitter Agents; Vasodilator Agents | 1990 |
Development of dopaminergic drugs for the chronic treatment of congestive heart failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Deoxyepinephrine; Dopamine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Receptors, Dopamine | 1990 |
How to select a drug for the long-term treatment of chronic heart failure.
Topics: Cardiotonic Agents; Deoxyepinephrine; Heart Failure; Humans | 1990 |
The safety profile of ibopamine, an alternative substance for treatment of chronic heart failure.
Topics: Cardiotonic Agents; Deoxyepinephrine; Electrocardiography; Heart Failure; Hemodynamics; Humans; Vasodilator Agents; Water-Electrolyte Balance | 1990 |
Pharmacotherapeutic profile of ibopamine in heart failure.
Topics: Adrenergic beta-Agonists; Aged; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Dopamine Agents; Heart Failure; Hemodynamics; Humans; Middle Aged; Receptors, Adrenergic, beta; Receptors, Dopamine; Renin-Angiotensin System; Vasodilator Agents | 1989 |
Cardiovascular and renal action of dopaminergic prodrugs.
Topics: Animals; Cardiotonic Agents; Cats; Chemical Phenomena; Chemistry; Deoxyepinephrine; Dihydroxyphenylalanine; Dogs; Dopamine; Dopamine Agents; Drug Design; Female; Heart Failure; Hemodynamics; Humans; Kidney; Levodopa; Male; Prodrugs; Rabbits; Rats; Vasodilator Agents | 1989 |
The role of dopaminergic agents and the dopamine receptor in treatment for CHF.
Topics: Benzazepines; Deoxyepinephrine; Dobutamine; Dopamine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Receptors, Dopamine | 1989 |
Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Chronic Disease; Deoxyepinephrine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Vasodilator Agents | 1989 |
Ibopamine--how should it be used?
Topics: Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Dopamine; Heart Failure; Hemodynamics; Humans | 1988 |
51 trial(s) available for ibopamine and Heart Failure
| Article | Year |
|---|---|
Low pulse pressure is an independent predictor of mortality and morbidity in non ischaemic, but not in ischaemic advanced heart failure patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Deoxyepinephrine; Disease Progression; Dopamine Agonists; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Young Adult | 2009 |
[Echocardiographic and polygraphic study of acute/effects of Ibopamine on cardiac performance].
Topics: Adult; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Echocardiography; Heart; Heart Failure; Hemodynamics; Humans; Male | 1983 |
Failure of "effective" treatment for heart failure to improve normal customary activity.
Topics: Activities of Daily Living; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronic Disease; Deoxyepinephrine; Dopamine Agonists; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Indoles; Isosorbide Dinitrate; Male; Middle Aged; Single-Blind Method; Treatment Failure; Vasodilator Agents | 1995 |
[Acute hemodynamic effects of ibopamine, captopril, and placebo in patients with severe heart failure].
Topics: Adolescent; Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cardiomyopathies; Deoxyepinephrine; Diuretics; Double-Blind Method; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Rest; Severity of Illness Index | 1995 |
Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group.
Topics: Aldosterone; Cardiotonic Agents; Deoxyepinephrine; Digoxin; Diuretics; Dopamine Agonists; Double-Blind Method; Electrocardiography, Ambulatory; Female; Furosemide; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Renin; Time Factors | 1995 |
[Comparative study between ibopamine and captopril in mild and moderate heart failure. A double-blind study].
Topics: Adult; Aged; Captopril; Cardiotonic Agents; Clinical Protocols; Deoxyepinephrine; Double-Blind Method; Electrocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged | 1994 |
Dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine.
Topics: Administration, Oral; Aged; Aldosterone; Analysis of Variance; Blood Pressure; Deoxyepinephrine; Dihydroergotoxine; Dopamine; Dopamine Agonists; Epinephrine; Heart Failure; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Norepinephrine; Radionuclide Imaging; Renin; Stroke Volume; Vascular Resistance | 1995 |
Renal and systemic hemodynamic effects of ibopamine in patients with mild to moderate congestive heart failure.
Topics: Aged; Aldosterone; Deoxyepinephrine; Female; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Male; Middle Aged; Renal Circulation; Renin; Sodium; Vasodilator Agents | 1995 |
Acute effect of ibopamine and isosorbide mononitrate on blood volume distribution in congestive heart failure.
Topics: Aged; Blood Volume; Deoxyepinephrine; Double-Blind Method; Drug Interactions; Female; Heart Failure; Hemodynamics; Humans; Isosorbide; Male; Middle Aged; Radionuclide Imaging; Technetium Tc 99m Pentetate | 1994 |
Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT).
Topics: Adolescent; Adult; Aged; Aldosterone; Cardiotonic Agents; Deoxyepinephrine; Digoxin; Dopamine Agents; Double-Blind Method; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Netherlands; Norepinephrine; Prospective Studies; Renin; Severity of Illness Index | 1993 |
Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor.
Topics: Aged; Coronary Disease; Deoxyepinephrine; Dopamine Agents; Double-Blind Method; Down-Regulation; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Receptors, Dopamine; Ventricular Function, Left | 1994 |
The effects of oral ibopamine in patients with mild heart failure--a double blind placebo controlled comparison to furosemide. The Ibopamine Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cardiac Output; Cardiotonic Agents; Child; Deoxyepinephrine; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Quality of Life | 1993 |
Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Autonomic Nervous System; Blood Gas Analysis; Cardiotonic Agents; Chemotherapy, Adjuvant; Chronic Disease; Deoxyepinephrine; Double-Blind Method; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Radioimmunoassay; Renin | 1996 |
Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators.
Topics: Adult; Aged; Aged, 80 and over; Cause of Death; Deoxyepinephrine; Dopamine Agonists; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Survival Rate; Treatment Outcome | 1997 |
A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure.
Topics: Adult; Cross-Over Studies; Deoxyepinephrine; Diuretics; Dopamine Agonists; Double-Blind Method; Exercise Test; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1997 |
Ibopamine and survival in severe congestive heart failure: PRIME II.
Topics: Cardiotonic Agents; Cause of Death; Deoxyepinephrine; Drug Monitoring; Heart Failure; Humans; Placebos; Safety; Stochastic Processes; Survival Rate | 1997 |
Ibopamine and survival in severe congestive heart failure: PRIME II.
Topics: Amiodarone; Anti-Arrhythmia Agents; Area Under Curve; Cardiotonic Agents; Cause of Death; Deoxyepinephrine; Dopamine Agonists; Heart Failure; Humans; Survival Rate | 1997 |
Comparison of captopril and ibopamine in mild to moderate heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Deoxyepinephrine; Dopamine Agonists; Double-Blind Method; Drug Administration Schedule; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies | 1997 |
Evaluation of ibopamine plus prazosin in congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Adult; Cross-Over Studies; Deoxyepinephrine; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Monitoring, Physiologic; Placebos; Prazosin; Vasodilator Agents | 1998 |
Renal function, neurohormonal activation, and survival in patients with chronic heart failure.
Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Cardiac Output; Cardiotonic Agents; Catecholamines; Chronic Disease; Deoxyepinephrine; Dopamine; Epinephrine; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Male; Middle Aged; New York; Norepinephrine; Predictive Value of Tests; Prognosis; Prospective Studies; Protein Precursors; Renin; Renin-Angiotensin System; Survival Analysis; Ventricular Dysfunction, Left; Ventricular Function, Left | 2000 |
Achieving appropriate endpoints in heart failure trials: the PRIME-II protocol. The Second Perspective Randomised study of Ibopamine on Mortality and Efficacy.
Topics: Clinical Protocols; Deoxyepinephrine; Evaluation Studies as Topic; Heart Failure; Humans; Patient Selection; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Survival Analysis; Vasodilator Agents | 1999 |
Effects of acute and chronic ibopamine administration on resting and exercise hemodynamics, plasma catecholamines and functional capacity of patients with chronic congestive heart failure.
Topics: Deoxyepinephrine; Dopamine Agents; Double-Blind Method; Epinephrine; Exercise; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Time Factors | 1992 |
[Ibopamine in the treatment of congestive heart failure. Multicenter follow-up study].
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Deoxyepinephrine; Drug Evaluation; Female; Heart Failure; Humans; Male; Middle Aged; Portugal; Prospective Studies | 1992 |
Hemodynamic comparison of combined therapy by nitroglycerin tape and ibopamine with combination of nitroglycerin tape and nifedipine.
Topics: Administration, Cutaneous; Administration, Oral; Cardiac Complexes, Premature; Cardiotonic Agents; Deoxyepinephrine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Nifedipine; Nitroglycerin; Vasodilator Agents | 1990 |
[Ibopamine in treatment of mild heart failure, a comparison with hydrochlorothiazide].
Topics: Aged; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Hydrochlorothiazide; Male | 1991 |
Safety of ibopamine therapy in congestive heart failure. Ibopamine cohort study: baseline and 1-year results.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angina Pectoris; Arrhythmias, Cardiac; Blood Pressure; Cardiotonic Agents; Deoxyepinephrine; Digoxin; Drug Prescriptions; Drug Therapy, Combination; Electrocardiography; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Product Surveillance, Postmarketing; Prognosis; Risk Factors | 1991 |
Comparative effects of long-term therapy with captopril and ibopamine in chronic congestive heart failure in old patients.
Topics: Aged; Captopril; Deoxyepinephrine; Double-Blind Method; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Time Factors; Vasodilator Agents | 1991 |
Comparative effects of ibopamine and captopril in mild congestive heart failure. Focus on the long-term effects of inodilation on ventricular arrhythmias.
Topics: Adult; Aged; Captopril; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Long-Term Care; Middle Aged; Tachycardia; Vasodilator Agents | 1990 |
[Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure].
Topics: Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Dilated; Coronary Disease; Cyclic GMP; Deoxyepinephrine; Diuretics; Dopamine; Electrolytes; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Natriuresis; Urodynamics | 1990 |
Single-dose effects of ibopamine hydrochloride on renal function in patients with congestive heart failure.
Topics: Acute Kidney Injury; Administration, Oral; Aged; Deoxyepinephrine; Diuretics; Female; Heart Failure; Humans; Kidney Function Tests; Male; Middle Aged; Osmolar Concentration; Potassium; Sodium | 1990 |
Ibopamine does not affect insulin resistance in patients with type I diabetes.
Topics: Adult; Blood Glucose; Cardiotonic Agents; Deoxyepinephrine; Diabetes Mellitus, Type 1; Female; Heart Failure; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Vasodilator Agents | 1990 |
Safety of ibopamine in type II diabetic patients with mild chronic heart failure. A double-blind cross-over study.
Topics: Aged; C-Peptide; Cardiotonic Agents; Deoxyepinephrine; Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Acids, Nonesterified; Female; Glucose Tolerance Test; Heart Failure; Hemodynamics; Humans; Lactates; Lactic Acid; Male; Vasodilator Agents | 1990 |
Treatment of mild chronic congestive heart failure with ibopamine, hydrochlorothiazide, ibopamine plus hydrochlorothiazide or placebo. A double-blind comparative study.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Hydrochlorothiazide; Male; Middle Aged; Vasodilator Agents; Water-Electrolyte Balance | 1990 |
Ibopamine versus digoxin in the treatment of mild congestive heart failure. A double-blind, randomized, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Deoxyepinephrine; Digoxin; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Vasodilator Agents | 1990 |
Extracardial effects of oral ibopamine versus furosemide in patients with mild or moderate heart failure. A double-blind, randomized trial.
Topics: Administration, Oral; Adult; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Renal Circulation; Renin; Vasodilator Agents; Water-Electrolyte Balance | 1990 |
Ibopamine in the treatment of mild chronic heart failure in elderly patients. A double-blind, placebo-controlled study.
Topics: Aged; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Vasodilator Agents | 1990 |
Absence of proarrhythmic effects of ibopamine in patients with congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Double-Blind Method; Drug Evaluation; Female; Heart Failure; Humans; Italy; Male; Middle Aged; Multicenter Studies as Topic; Random Allocation; Vasodilator Agents | 1989 |
Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure.
Topics: Aged; Aldosterone; Deoxyepinephrine; Depression, Chemical; Dihydroergotoxine; Dopamine; Dopamine Agents; Heart Failure; Humans; Male; Middle Aged; Random Allocation; Renin; Renin-Angiotensin System | 1989 |
Ibopamine vs. digoxin in chronic heart failure: a double-blind, crossover study.
Topics: Adult; Aged; Cardiotonic Agents; Chronic Disease; Deoxyepinephrine; Digoxin; Dopamine; Double-Blind Method; Drug Evaluation; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Oxygen Consumption; Physical Endurance; Random Allocation; Vasodilator Agents | 1989 |
Long-term therapy of chronic congestive heart failure with ibopamine: a multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Chronic Disease; Deoxyepinephrine; Dopamine; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Italy; Male; Middle Aged; Multicenter Studies as Topic; Survival Rate; Time Factors; Vasodilator Agents | 1989 |
The long-term efficacy of ibopamine in treating patients with severe heart failure: a multicenter investigation.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Digitalis Glycosides; Diuretics; Dopamine; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Female; Heart Failure; Humans; Italy; Male; Middle Aged; Multicenter Studies as Topic; Physical Endurance; Random Allocation; Time Factors; Vasodilator Agents | 1989 |
Peripheral hemodynamic effects of ibopamine in patients with congestive heart failure. A placebo-controlled, double-blind study.
Topics: Aged; Aged, 80 and over; Deoxyepinephrine; Double-Blind Method; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Plethysmography; Regional Blood Flow; Sulpiride; Vasodilator Agents | 1989 |
Ibopamine versus hydrochlorothiazide/amiloride in patients with mild congestive heart failure. SK & F Ibopamine Working Group.
Topics: Amiloride; Body Weight; Cardiotonic Agents; Deoxyepinephrine; Double-Blind Method; Drug Combinations; Exercise Test; Female; Heart Failure; Humans; Hydrochlorothiazide; Male; Middle Aged; Vasodilator Agents | 1989 |
Influence of ibopamine on heart rate and arrhythmic pattern in patients with congestive heart failure. A double-blind multicentre study.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Double-Blind Method; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Multicenter Studies as Topic | 1989 |
Ibopamine as a substitute for digitalis in patients with congestive heart failure on chronic digoxin therapy. Smith Kline and French Ibopamine Group.
Topics: Adult; Aged; Arrhythmias, Cardiac; Deoxyepinephrine; Digoxin; Dopamine; Echocardiography; Exercise Test; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged | 1989 |
Ibopamine--how should it be used?
Topics: Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Dopamine; Heart Failure; Hemodynamics; Humans | 1988 |
Effects of ibopamine in combination with furosemide on renal function in patients with chronic congestive heart failure.
Topics: Aged; Blood Glucose; Chlorides; Creatinine; Deoxyepinephrine; Dopamine; Drug Therapy, Combination; Electrolytes; Female; Furosemide; Heart Failure; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; Urination | 1988 |
Positive inotropic effects of ibopamine in patients with congestive heart failure. A multicenter investigation.
Topics: Adult; Aged; Blood Chemical Analysis; Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Dopamine; Double-Blind Method; Electrocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Random Allocation | 1986 |
Ibopamine post-marketing surveillance. First report from a parallel-cohorts survey ongoing since April 1st, 1985.
Topics: Aged; Angina Pectoris; Arrhythmias, Cardiac; Cardiotonic Agents; Cardiovascular Diseases; Deoxyepinephrine; Dopamine; Drug Interactions; Electrocardiography; Evaluation Studies as Topic; Female; Heart Failure; Humans; Male; Middle Aged; Product Surveillance, Postmarketing; Prognosis; Risk Factors; Sex Factors; Socioeconomic Factors; Thromboembolism | 1987 |
Comparison of the acute hemodynamic effects of ibopamine and dopamine in chronic congestive heart failure.
Topics: Adult; Cardiac Output; Cardiotonic Agents; Chronic Disease; Deoxyepinephrine; Dopamine; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1986 |
Effects of digoxin, placebo and ibopamine on exercise tolerance and cardiac rhythm of patients with chronic post-infarct left ventricular failure.
Topics: Aged; Arrhythmias, Cardiac; Cardiotonic Agents; Deoxyepinephrine; Digoxin; Dopamine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Physical Exertion | 1986 |
69 other study(ies) available for ibopamine and Heart Failure
| Article | Year |
|---|---|
Sympathomimetic amines: potential clinical applications in ischemic heart disease.
Topics: Animals; Coronary Disease; Deoxyepinephrine; Dobutamine; Dogs; Dopamine; Heart Failure; Humans; Levodopa; Myocardial Contraction; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Dopamine; Sympathomimetics | 1982 |
Haemodynamic evaluation of ibopamine in severe congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Electrocardiography; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Stroke Volume | 1984 |
Ibopamine in very severe congestive heart failure: pilot haemodynamic invasive assessment.
Topics: Aged; Blood Pressure; Cardiac Output; Deoxyepinephrine; Diuretics; Dopamine; Heart Failure; Hemodynamics; Humans; Middle Aged; Time Factors | 1983 |
[Preliminary results of the action of long-term oral treatment with the di-isobutyric ester of N-methyldopamine (SB 7505) in 10 patients with severe cardiocirculatory decompensation].
Topics: Aged; Aortic Valve; Blood Pressure; Cardiomyopathies; Deoxyepinephrine; Diuresis; Diuretics; Dopamine; Heart Failure; Heart Valve Diseases; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Stroke Volume; Systole | 1980 |
Double-blind haemodynamic study of a new dopamine derivative (diisobutyric ester of N-methyl-dopamine) orally active in chronic congestive heart failure.
Topics: Aged; Blood Pressure; Deoxyepinephrine; Dopamine; Double-Blind Method; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Circulation; Vascular Resistance | 1981 |
The effects of ibopamine on glomerular filtration rate and plasma norepinephrine remain preserved during prolonged treatment in patients with congestive heart failure.
Topics: Adult; Aged; Aldosterone; Deoxyepinephrine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Kidney; Long-Term Care; Male; Middle Aged; Norepinephrine; Renin | 1995 |
Pharmacologic treatment of congestive heart failure.
Topics: Cardiotonic Agents; Deoxyepinephrine; Diuretics; Heart Failure; Humans; Vasodilator Agents | 1995 |
Congestive heart failure. Drug therapy: central or peripheral approach?
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Carnitine; Coenzymes; Deoxyepinephrine; Dopamine Agents; Heart Failure; Humans; Taurine; Ubiquinone; Vasodilator Agents | 1993 |
[Drug of the month. Ibopamine (Scandine, Idopamil)].
Topics: Cardiotonic Agents; Deoxyepinephrine; Heart Failure; Humans; Vasodilator Agents | 1994 |
Effects of ibopamine on renal haemodynamics in patients with severe congestive heart failure.
Topics: Aged; Aged, 80 and over; Deoxyepinephrine; Dopamine Agents; Drug Evaluation; Glomerular Filtration Rate; Heart Failure; Humans; Middle Aged; Potassium; Renal Circulation; Sodium | 1993 |
[The neurohumoral mechanisms are already altered before the patient may have symptoms of heart failure. Interview by Salvador Giménez].
Topics: Deoxyepinephrine; Dopamine Agents; Heart Failure; Humans; Neurotransmitter Agents | 1993 |
Ibopamine-induced reversible leukopenia during treatment for congestive heart failure.
Topics: Aged; Aged, 80 and over; Deoxyepinephrine; Dopamine Agents; Female; Heart Failure; Humans; Leukopenia | 1993 |
Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine.
Topics: Animals; Aortic Valve Stenosis; Culture Techniques; Deoxyepinephrine; Disease Models, Animal; Endothelium, Vascular; Epinephrine; Heart Failure; Male; Methacholine Chloride; Myocardial Infarction; Norepinephrine; Phenylephrine; Rats; Rats, Wistar; Vasodilator Agents | 1993 |
Effects of ibopamine on the increase in plasma norepinephrine levels during exercise in congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Deoxyepinephrine; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Oxygen Consumption; Physical Exertion | 1993 |
[Clinical efficacy of oral dopaminergic agents: new findings].
Topics: Administration, Oral; Adrenergic alpha-Agonists; Deoxyepinephrine; Dopamine; Dopamine Agents; Dopamine Agonists; Heart Failure; Hemodynamics; Humans; Kidney; Levodopa; Norepinephrine; Receptors, Dopamine | 1995 |
[Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?].
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Cyclooxygenase Inhibitors; Deoxyepinephrine; Digitalis Glycosides; Diuretics; Dobutamine; Dopamine; Dopamine Agonists; Drug Therapy, Combination; Heart Failure; Humans; Nitrates; Phosphodiesterase Inhibitors; Vasodilator Agents | 1995 |
Treating chronic heart failure: time to take stock.
Topics: Chronic Disease; Deoxyepinephrine; Dopamine Agonists; Heart Failure; Humans; Randomized Controlled Trials as Topic; Receptors, Dopamine | 1997 |
Treatment of mild heart failure: the place of diuretics and ibopamine.
Topics: Chronic Disease; Deoxyepinephrine; Diuretics; Dopamine Agonists; Drug Therapy, Combination; Heart Failure; Humans; Survival Rate | 1997 |
PRIME II (Second Prospective Randomized Study of Ibupamine on Mortality and Efficacy): another disappointment in heart failure therapy.
Topics: Deoxyepinephrine; Dopamine Agonists; Drug Evaluation; Heart Failure; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Safety; Survival Rate; Vasodilator Agents | 1997 |
Dopamine agonists in heart failure: an untimely death.
Topics: Deoxyepinephrine; Dopamine Agonists; Heart Failure; Humans; Netherlands | 1997 |
A nested case-control study on mortality in users of ibopamine.
Topics: Aged; Case-Control Studies; Deoxyepinephrine; Dopamine Agonists; Female; Heart Failure; Humans; Logistic Models; Male; Netherlands; Odds Ratio; Risk Factors | 1997 |
Risk factors for mortality in users of ibopamine.
Topics: Aged; Cohort Studies; Deoxyepinephrine; Dopamine Agonists; Female; Heart Failure; Humans; Male; Middle Aged; Netherlands; Risk Factors | 1998 |
[Risk factors for dying among ibopamine users].
Topics: Adult; Aged; Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Female; Heart Failure; Humans; Male; Middle Aged; Risk Factors; Survival Rate | 1999 |
[Risk factors for dying among ibopamine users].
Topics: Aged; Cardiotonic Agents; Clinical Trials as Topic; Deoxyepinephrine; Heart Failure; Humans; Risk Factors | 1999 |
Confounding by contraindication in a nationwide cohort study of risk for death in patients taking ibopamine.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Cohort Studies; Confounding Factors, Epidemiologic; Contraindications; Deoxyepinephrine; Dopamine Agonists; Female; Heart Failure; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Surveys and Questionnaires | 2001 |
Ibopamine as a valuable adjunct and substitute for dopamine in bridging therapy before heart transplantation.
Topics: Adult; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Drug Therapy, Combination; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Postoperative Complications; Preoperative Care | 1992 |
Effects of intravenous epinine administration on left ventricular systolic performance, coronary hemodynamics, and circulating catecholamines in patients with heart failure.
Topics: Adult; Aged; Catecholamines; Coronary Circulation; Deoxyepinephrine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Ventricular Function, Left | 1992 |
Hemodynamic effects and pharmacokinetics of long-term therapy with ibopamine in patients with chronic heart failure.
Topics: Administration, Oral; Aged; Cardiotonic Agents; Chronic Disease; Deoxyepinephrine; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Long-Term Care; Male; Metabolic Clearance Rate; Middle Aged | 1992 |
Ibopamine: a new pharmacotherapeutic approach to heart failure. Proceedings of a symposium. October 19, 1989, Kyoto, Japan.
Topics: Deoxyepinephrine; Dopamine Agents; Heart Failure; Humans | 1991 |
Dopaminergic drugs in the management of chronic heart failure.
Topics: Adult; Deoxyepinephrine; Dopamine Agents; Female; Heart Failure; Hemodynamics; Humans; Levodopa; Male; Middle Aged; Myocardial Contraction; Pilot Projects | 1991 |
Electrophysiologic profile of ibopamine in patients with congestive heart failure and ventricular tachycardia and relation to its effects on hemodynamics and plasma catecholamines.
Topics: Adult; Aged; Blood Pressure; Cardiac Pacing, Artificial; Catecholamines; Deoxyepinephrine; Dopamine Agents; Electrocardiography; Electrocardiography, Ambulatory; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Stroke Volume; Tachycardia; Vascular Resistance | 1991 |
Dopamine agonists, a new perspective in cardiovascular therapy?
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Deoxyepinephrine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic | 1991 |
[Changes in the cardio-thoracic index during the treatment with ibopamine].
Topics: Administration, Oral; Aged; Aged, 80 and over; Cardiotonic Agents; Deoxyepinephrine; Female; Heart Failure; Humans; Middle Aged; Radiography, Thoracic; Time Factors; Vasodilator Agents | 1991 |
[Dopamine and dopaminergic drugs as therapeutic agents in heart failure].
Topics: Deoxyepinephrine; Dobutamine; Dopamine; Dopamine Agents; Heart Failure; Hemodynamics; Humans; Vasodilator Agents | 1990 |
Long-term treatment of congestive heart failure with oral ibopamine. Effects of rhythm disorders and neurohormonal alterations.
Topics: Administration, Oral; Aged; Aldosterone; Angiotensin II; Arrhythmias, Cardiac; Cardiotonic Agents; Deoxyepinephrine; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Failure; Hemodynamics; Humans; Long-Term Care; Male; Middle Aged; Neurotransmitter Agents; Norepinephrine; Renin; Vasodilator Agents | 1990 |
Efficacy and safety of ibopamine in congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Deoxyepinephrine; Dopamine Agents; Drug Evaluation; Electrocardiography; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Safety | 1990 |
Ibopamine in the management of congestive heart failure.
Topics: Deoxyepinephrine; Heart Failure; Humans | 1990 |
Onset of cardiovascular action after oral ibopamine. Early hemodynamic effects of single and repeated doses in patients with idiopathic dilated myocardiopathy.
Topics: Aged; Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Deoxyepinephrine; Dopamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Circulation; Vasodilator Agents | 1990 |
Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations.
Topics: Administration, Oral; Adult; Cardiotonic Agents; Creatinine; Deoxyepinephrine; Dopamine; Drug Administration Schedule; Drug Evaluation; Echocardiography; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Sodium; Survival Rate; Vasodilator Agents | 1989 |
Ibopamine: long-term safety study in patients with congestive heart failure. The Italian Ibopamine Working Group.
Topics: Adolescent; Adult; Aged; Cardiotonic Agents; Demography; Deoxyepinephrine; Diuretics; Dopamine; Drug Tolerance; Female; Heart Failure; Humans; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Time Factors; Vasodilator Agents | 1989 |
[Role of ibopamine in cardiac insufficiency in auricular fibrillation. Presentation of a case].
Topics: Aged; Atrial Fibrillation; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Heart Failure; Humans; Male | 1989 |
[Acute and chronic effects of a new oral inotropic agent, ibopamine hydrochloride, on hemodynamic and metabolic responses to ergometer exercise in patients with severe congestive heart failure].
Topics: Administration, Oral; Adult; Aged; Cardiotonic Agents; Deoxyepinephrine; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1989 |
Dopamine receptors: applications in clinical cardiology.
Topics: Administration, Oral; Arrhythmias, Cardiac; Benzazepines; Bromocriptine; Deoxyepinephrine; Fenoldopam; Heart Failure; Hemodynamics; Humans; Levodopa; Receptors, Dopamine; Structure-Activity Relationship; Vascular Resistance | 1985 |
The role of adrenergic and dopamine receptors.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiotonic Agents; Deoxyepinephrine; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Levodopa; Receptors, Adrenergic; Receptors, Dopamine | 1985 |
Clinical pharmacokinetics of ibopamine on different diseases and conditions.
Topics: Absorption; Administration, Oral; Adult; Aged; Aged, 80 and over; Biological Availability; Chemical Phenomena; Chemistry; Deoxyepinephrine; Digoxin; Dopamine; Dopamine Agents; Drug Interactions; Female; Food; Heart Failure; Humans; Kidney Failure, Chronic; Liver Cirrhosis; Male; Middle Aged; Quinidine; Vasodilator Agents | 1988 |
Noninvasive assessment of diastolic and systolic properties of ibopamine in patients with congestive heart failure.
Topics: Adult; Aged; Deoxyepinephrine; Diastole; Dopamine; Echocardiography; Echocardiography, Doppler; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Systole | 1989 |
[Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure].
Topics: Aged; Aged, 80 and over; Aldosterone; Carbon Dioxide; Cardiotonic Agents; Catecholamines; Deoxyepinephrine; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Male; Oxygen; Renin | 1987 |
Lack of tolerance development during chronic ibopamine administration to patients with congestive heart failure.
Topics: Adult; Aged; Chronic Disease; Deoxyepinephrine; Drug Tolerance; Heart Failure; Humans; Male; Middle Aged; Vasodilator Agents | 1988 |
Treatment of heart failure following chronic cor pulmonale with ibopamine.
Topics: Aged; Aged, 80 and over; Chronic Disease; Deoxyepinephrine; Diuretics; Dopamine; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Male; Middle Aged; Pulmonary Heart Disease | 1988 |
Ibopamine kinetics after single and multiple dosing in patients with congestive heart failure.
Topics: Aged; Deoxyepinephrine; Dopamine; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Middle Aged | 1988 |
[Blood levels of activated renin, aldosterone, catecholamine in congestive heart failure. II. Effects of dopaminergic stimulation with a dopamine agonist: ibopamine].
Topics: Adult; Aldosterone; Blood Volume; Catecholamines; Deoxyepinephrine; Dopamine; Female; Heart Failure; Humans; Male; Middle Aged; Renin | 1987 |
Effect of ibopamine on the failing heart at rest and during isometric exercise: a noninvasive study.
Topics: Adult; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Heart Failure; Hemodynamics; Humans; Isometric Contraction; Male; Middle Aged; Rest | 1988 |
Ibopamine kinetics after a single oral dose in patients with congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Chromatography, High Pressure Liquid; Deoxyepinephrine; Dopamine; Female; Half-Life; Heart Failure; Humans; Male; Middle Aged; Vasodilator Agents | 1988 |
Ibopamine in congestive heart failure refractory to digitalis, diuretics, and captopril.
Topics: Aged; Captopril; Cardiotonic Agents; Creatinine; Deoxyepinephrine; Digitalis Glycosides; Diuretics; Dopamine; Drug Resistance; Echocardiography; Electrocardiography; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Sodium | 1986 |
Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
Topics: Aged; Aldosterone; Blood Gas Analysis; Cardiotonic Agents; Catecholamines; Deoxyepinephrine; Dopamine; Electrolytes; Female; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Male; Renin | 1986 |
Effects of ibopamine on acute cardiac failure following experimental coronary occlusion in dogs.
Topics: Animals; Cardiotonic Agents; Coronary Disease; Deoxyepinephrine; Dogs; Dopamine; Electrocardiography; Female; Heart Failure; Hemodynamics; Male | 1986 |
Evaluation of acute hemodynamic effects and pharmacokinetic behaviour of ibopamine in patients with severe heart failure.
Topics: Adult; Aged; Deoxyepinephrine; Diuretics; Dopamine; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Kinetics; Male; Middle Aged; Time Factors; Vascular Resistance | 1986 |
Hemodynamic evaluation of ibopamine in patients with refractory congestive heart failure.
Topics: Adult; Aged; Cardiac Catheterization; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Drug Resistance; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Time Factors | 1986 |
Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure.
Topics: Adult; Aged; Cardiac Catheterization; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Time Factors | 1986 |
Effects of ibopamine on peripheral hemodynamics: a strain gauge plethysmographic study in patients with congestive heart failure.
Topics: Aged; Blood Pressure; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Plethysmography; Regional Blood Flow; Time Factors | 1986 |
Multicenter study on the clinical efficacy of chronic ibopamine administration.
Topics: Aged; Blood Pressure; Cardiotonic Agents; Deoxyepinephrine; Diuresis; Dopamine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged | 1986 |
Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure.
Topics: Adult; Aged; Body Weight; Cardiotonic Agents; Chronic Disease; Deoxyepinephrine; Dopamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Monitoring, Physiologic; Time Factors | 1986 |
A survey of 311 patients receiving ibopamine mainly during hospital treatment for severe congestive heart failure.
Topics: Age Factors; Aged; Blood Pressure; Body Weight; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Monitoring, Physiologic; Sex Factors | 1986 |
[Comparison of the acute effects of ibopamine with those of dopamine on the echocardiographic parameters of systolic function of the heart in congestive cardiac failure].
Topics: Adult; Aged; Deoxyepinephrine; Dopamine; Echocardiography; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Systole | 1986 |
Effects of long-term therapy with oral ibopamine on resting hemodynamics and exercise capacity in patients with heart failure: relationship to the generation of N-methyldopamine and to plasma norepinephrine levels.
Topics: Administration, Oral; Cardiac Output; Deoxyepinephrine; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Physical Exertion; Pulmonary Wedge Pressure; Rest; Stroke Volume; Time Factors | 1986 |
Inhibition of prolactin and aldosterone secretion by the dopamine derivative ibopamine.
Topics: Adult; Aldosterone; Deoxyepinephrine; Dopamine; Female; Growth Hormone; Heart Failure; Humans; Hydrocortisone; Male; Middle Aged; Prolactin; Time Factors; Vasodilator Agents | 1986 |
Acute haemodynamic effects of ibopamine in patients with severe congestive heart failure.
Topics: Adult; Aged; Cardiac Catheterization; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Circulation; Stroke Volume; Vascular Resistance | 1985 |
Hemodynamic advantage of combined administration of oral ibopamine and nitroprusside in patients with ischemic and idiopathic congestive cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Deoxyepinephrine; Dopamine; Drug Therapy, Combination; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroprusside | 1985 |
[Hemodynamic effects induced by the combined administration of sodium nitroprusside and ibopamine in patients with congestive heart decompensation].
Topics: Adult; Aged; Cardiotonic Agents; Deoxyepinephrine; Dopamine; Drug Therapy, Combination; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Male; Nitroprusside | 1985 |